Virology
A section of Microorganisms (ISSN 2076-2607).
Section Information
Viruses represent a significant part of the microbial universe, and they are the causative agents of many diseases impacting the global public health landscape. This section is dedicated to significant findings about viruses of animals, plants, insects, and bacteria. With the expanding number of viral spill-over events and the increase in vaccine hesitancy in many parts of the world, research on “old” and newly emerging viral diseases is welcome.
Viruses require a host for propagation and dissemination, so the elucidation of the virus–host interface is critically important. Genetic manipulation and molecular characterization of viruses through in vitro and cell culture experiments helps to form the needed foundation for advanced studies. Animal model development is generally used to expand our understanding of disease and pathology and is a necessity for the evaluation of vaccines and therapeutics. In addition, ecological aspects—such as the search for viral reservoirs—cannot be ignored. We encourage the submission of manuscripts from all areas of basic and translational virology that expand our understanding of viral transmission, molecular virology, animal models, pathogenesis, and countermeasure development.
In this section, original and review articles reporting state-of-the-art developments and covering basic and applied aspects of virology are welcome. Articles that are outside the scope of the subject matter listed here may be referred to another section of Microorganisms.
Keywords
- Antivirals and vaccines
- Cell biology
- Chronic/persistent viral diseases
- Detection and diagnosis
- Disease and viral pathogenesis
- Ecology
- Emerging and neglected viruses/viral diseases
- Epidemiology and public health
- Host response
- Host–virus interactions
- Immunology
- Laboratory methods
- Molecular virology
- Pathology
- Phylogenetics and molecular genetics
- Preclinical studies
- Viral lifecycle and particle morphology
- Virus evolution
- Zoonotic diseases
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Navigating Novel Viral Challenges: Understanding, Tracking, and Mitigating Emerging Threats (Deadline: 30 September 2024)
- Molecular Mechanisms of Viral Persistence and Immune Evasion (Deadline: 30 September 2024)
- Adeno-Associated Virus Biology and AAV Vector-Mediated Gene Therapy (Deadline: 30 September 2024)
- The Viral Proteomics: Decoding the Proteome of Pathogenic Viruses (Deadline: 30 September 2024)
- Diversity and Pathogenesis of Common Human and Animal Viruses (Deadline: 15 October 2024)
- Emerging Viruses and Antiviral Drugs, 2nd Edition (Deadline: 15 October 2024)
- Clinical Viral Infections and Autoimmunity (Deadline: 15 October 2024)
- Climate Change and Emerging Arboviruses (Deadline: 15 October 2024)
- Application of Omics in Virus Research (Deadline: 25 October 2024)
- Viral Infection and Immunity (Deadline: 31 October 2024)
- Advances in Viral Metagenomics (Deadline: 15 November 2024)
- Viral Diseases: Current Research and Future Directions (Deadline: 15 November 2024)
- Ecology of Influenza A Viruses: 2nd Edition (Deadline: 15 November 2024)
- Editorial Board Members’ Collection Series: Hepatitis Viruses: Who They Are and Consequences (Deadline: 30 November 2024)
- Recent Advances in Antivirals for Emerging Viruses 3.0 (Deadline: 30 November 2024)
- Emerging Viral Zoonoses, Second Edition (Deadline: 15 December 2024)
- Common Clinical Viral Pathogens: Detection and Treatment (Deadline: 15 December 2024)
- Epidemiology of Hemorrhagic Fever Viruses (Deadline: 15 December 2024)
- Editorial Board Members’ Collection Series: SARS-CoV-2 and COVID (Deadline: 31 December 2024)
- Latest Review Papers in Virology 2024 (Deadline: 31 December 2024)
- New Knowledge in the Study of Coronaviruses: Towards One Health and Whole Genome Sequencing Approaches, 2nd Edition (Deadline: 15 January 2025)
- Diversity and Evolution of Plant and Fungal Viruses (Deadline: 15 January 2025)
- Viral Infection and The Discovery and Mode of Action of Novel Antivirals (Deadline: 31 January 2025)